A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1
Clinical trial NCT01623518 · COMPLETED
Trial details
- NCT number
- NCT01623518
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-03-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.